Printer Friendly

COMPANY INFORMATION
Labopharm Inc. 480 boul Armand-Frappier Laval, QC H7V 4B4 Tel: (450) 686-1017 Toll-free: (888) 686-1017 Fax: (450) 686-9141 Contact Name Mark A. D'Souza Industry Pharmaceuticals		Key Executives James R. Howard-Tripp, CEO Mark A. D'Souza, CFO Develops pharmaceutical products that incorporate the company's proprietary drug delivery technology Contramid®.
FP ADVISOR COVERAGE Labopharm Inc. • FP Corporate Analyzer • FP Directory of Directors • FP Corporate Surveys • FP Investor Reports • Ordering FP Products		TOP INDUSTRY PLAYERS Pharmaceuticals Company Name Revenue ($000s)  Biovail Corporation 807,909 Patheon Inc. 765,812 Cangene Corporation 238,751 Dragon Pharmaceutical, Inc. 162,127 Paladin Labs Inc. 82,744 (Links are to Snapshots.)
FINANCIAL RATIOS AS OF FEB 8/10 Listed Close 52-wk High 52-wk Low IAD Latest Dividend Yield 60-mo Beta TSX/DDS Nasdaq/DDSS $1.98 $3.40 $0.97 n.a. n.a. n.a. 0.79 Avg 20-day Volume P/E 12-mo EPS EPS Date 1-yr Return 3-yr Return 5-yr Return Market Cap. (000s) 800,488 n.a. $-0.60 Sept. 30/09 17.86% -33.52% -12.63% $114,718
ANNUAL FINANCIALS Periods ended: 12m Dec. 31/08 12m Dec. 31/07 12m Dec. 31/06 $000s $000s $000s Operating revenue 22,014 18,998 15,874 Net income (40,527) (36,575) (23,865) Total assets 69,851 99,539 128,634 $ $ $ Earnings per share* (0.71) (0.64) (0.46) % % % Return on equity (127.55) (55.63) n.m.   * Common
TRAILING 12-MONTH VALUES Periods ended: Sept. 30/09 Sept. 30/08 $000s $000s Operating revenue 22,284 20,217 Net income (34,470) (35,845) $ $ Earnings per share (0.61) (0.64)

COMPANY NEWS

Results for 'Labopharm Inc.' from past 30 days: 1 hit. Labopharm may be the win Canada's biotech sector needs; 'Great keypoint' National Post - Fri Feb 5 2010 - 558 words (Links are to articles.)